LD-2 disclosure · 4th Quarter - Report
ACADIA PHARMACEUTICALS
Client
- Location
- California · United States of America
Registrant
- Description
- Biopharmaceutical company
- Location
- San Diego, California, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Lobbyistsmr MICHAEL MATTOON · ms SARAH TODD TELLOCK
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Lobbyistsmr MICHAEL MATTOON · ms SARAH TODD TELLOCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Treasury, Dept of
Health Issues
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.